Michael Higgins
Stock Analyst at Ladenburg Thalmann
(1.84)
# 3,228
Out of 5,064 analysts
22
Total ratings
33.33%
Success rate
5.24%
Average return
Main Sectors:
Stocks Rated by Michael Higgins
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRDN Viridian Therapeutics | Downgrades: Neutral | n/a | $30.34 | - | 4 | May 9, 2024 | |
| FBRX Forte Biosciences | Upgrades: Buy | $69 | $18.42 | +273.34% | 3 | Apr 8, 2024 | |
| OVID Ovid Therapeutics | Reiterates: Buy | $7 | $1.40 | +400.00% | 1 | May 2, 2023 | |
| SCYX SCYNEXIS | Reiterates: Buy | $15 | $0.68 | +2,105.88% | 1 | Apr 3, 2023 | |
| ARTL Artelo Biosciences | Reiterates: Buy | $360 | $1.67 | +21,456.89% | 2 | Apr 3, 2023 | |
| RYTM Rhythm Pharmaceuticals | Reiterates: Buy | $35 | $101.74 | -65.60% | 3 | Mar 2, 2023 | |
| PTN Palatin Technologies | Maintains: Buy | $2 → $50 | $22.82 | +119.11% | 1 | Sep 9, 2022 | |
| PHGE BiomX | Maintains: Buy | $130 → $80 | $0.26 | +31,272.55% | 2 | May 12, 2022 | |
| NVAX Novavax | Downgrades: Sell | $105 | $6.47 | +1,522.87% | 2 | Aug 5, 2020 | |
| VIRT Virtu Financial | Upgrades: Buy | $29 | $33.98 | -14.66% | 2 | Jan 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | n/a | $4.92 | - | 1 | Sep 27, 2017 |
Viridian Therapeutics
May 9, 2024
Downgrades: Neutral
Price Target: n/a
Current: $30.34
Upside: -
Forte Biosciences
Apr 8, 2024
Upgrades: Buy
Price Target: $69
Current: $18.42
Upside: +273.34%
Ovid Therapeutics
May 2, 2023
Reiterates: Buy
Price Target: $7
Current: $1.40
Upside: +400.00%
SCYNEXIS
Apr 3, 2023
Reiterates: Buy
Price Target: $15
Current: $0.68
Upside: +2,105.88%
Artelo Biosciences
Apr 3, 2023
Reiterates: Buy
Price Target: $360
Current: $1.67
Upside: +21,456.89%
Rhythm Pharmaceuticals
Mar 2, 2023
Reiterates: Buy
Price Target: $35
Current: $101.74
Upside: -65.60%
Palatin Technologies
Sep 9, 2022
Maintains: Buy
Price Target: $2 → $50
Current: $22.82
Upside: +119.11%
BiomX
May 12, 2022
Maintains: Buy
Price Target: $130 → $80
Current: $0.26
Upside: +31,272.55%
Novavax
Aug 5, 2020
Downgrades: Sell
Price Target: $105
Current: $6.47
Upside: +1,522.87%
Virtu Financial
Jan 4, 2019
Upgrades: Buy
Price Target: $29
Current: $33.98
Upside: -14.66%
Sep 27, 2017
Reinstates: Buy
Price Target: n/a
Current: $4.92
Upside: -